Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
NCT06425198
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatic Impairment
Healthy Participants
Interventions
DRUG:
BMS-986278
Sponsor
Bristol-Myers Squibb